The dose-response analysis between BMI and common chronic diseases in northeast China

Jianxing Yu1, Yuchun Tao1, Jing Dou1

  • 1Epidemiology and Biostatistics, School of Public Health, No. 1163 Xinmin Street, Jilin University, Changchun, Jilin, 130021, China.

Scientific Reports
|March 11, 2018
PubMed

Insights

High body mass index (BMI) significantly increases the risk of chronic diseases like hypertension and dyslipidemia, particularly in middle-aged men. This risk escalates with age and is amplified by smoking and drinking habits.

Area of Science:

  • Public Health
  • Epidemiology
  • Chronic Disease Research

Background:

  • High body mass index (BMI) is a known risk factor for chronic diseases.
  • Previous studies lacked detailed dose-response analyses between BMI and chronic conditions.

Purpose of the Study:

  • To investigate the dose-response relationship between BMI and chronic diseases (hypertension, dyslipidemia, metabolic syndrome) in Northeast China.
  • To analyze age- and gender-specific trends in BMI and associated chronic disease risks.

Main Methods:

  • Utilized data from 16,412 participants aged 18-79 in Jilin province, China (2012).
  • Employed the lambda-mu-sigma (LMS) method for BMI trends and restricted cubic splines for non-linear dose-response analyses.
  • Examined the influence of smoking and drinking habits on BMI-related disease risks.

Main Results:

  • BMI trends varied by age and gender, with rapid increases in youth, stability in middle age, and slow decline in old age.
  • Odds ratios for chronic diseases increased significantly with BMI, especially in middle-aged and older adults, particularly men.
  • Smokers and drinkers exhibited higher BMI-related risks for chronic diseases.

Conclusions:

  • BMI has a significant dose-response relationship with hypertension, dyslipidemia, and metabolic syndrome.
  • The risk associated with high BMI escalates dramatically in middle age and old age, especially for men.
  • Lifestyle factors like smoking and drinking exacerbate the risk of chronic diseases linked to high BMI.

Related Concept Videos

Dose-Response Relationship: Overview01:03

Dose-Response Relationship: Overview

Agonists can bind with and activate receptors, resulting in the formation of drug-receptor complexes. Once formed, these complexes catalyze many biochemical processes at the cellular level and subsequently induce a pharmacologic response. The degree of response is directly proportional to the fraction of activated receptors, which in turn, depends on the concentration of the drug at the receptor site as well as the sensitivity of the receptor. An increase in the administered dose contributes to...
5.2K
Dose-Response Relationship: Potency and Efficacy01:22

Dose-Response Relationship: Potency and Efficacy

The potency of a drug is the measure of its ability to produce a biological response and can be compared by looking at the half-maximum effective concentration or EC50 values of different drugs. A lower EC50 value indicates higher potency of the drug. In the dose–response curve of two antihypertensive drugs, candesartan and irbesartan, a significant difference is observed in their EC50 values. A lower EC50 value for candesartan indicates that it is more potent than irbesartan, as it...
6.6K
Dose-Response Relationship: Selectivity and Specificity01:25

Dose-Response Relationship: Selectivity and Specificity

Drugs exert their therapeutic effects by interacting with receptors, enzymes, or ion channels that are present throughout the human body. The strength and duration of the interaction between a drug and its target receptor are characterized by the selectivity and specificity of the drug. Selectivity refers to a drug's strong preference for its intended target over other targets. For instance, isoprenaline, a non-selective β-adrenergic agonist, interacts with both β1- and...
9.9K
Dose Response Curve: Conventional Versus Nonmonotonic01:21

Dose Response Curve: Conventional Versus Nonmonotonic

The correlation between a drug's dosage and its impact on a biological system is a cornerstone of pharmacology and toxicology. Conventional dose–response curves, which include graded and quantal relationships, are key to this understanding. Graded dose–response curves depict the spectrum of a biological reaction to different doses within an individual, indicating that as the drug dosage increases, so does the intensity of the response. On the other hand, quantal dose–response...
1
Chronic Obstructive Pulmonary Disease01:24

Chronic Obstructive Pulmonary Disease

COPD is defined as a heterogeneous lung condition marked by persistent respiratory symptoms such as dyspnea, cough, and sputum production, caused by abnormalities in the airways that cause airflow obstruction.
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
2.6K
Chronic Kidney Disease I: Introduction01:25

Chronic Kidney Disease I: Introduction

Chronic Kidney Disease (CKD) arises when the kidneys progressively lose their ability to function, ultimately leading to end-stage renal disease. At this advanced stage, the kidneys can no longer filter waste or maintain essential body functions, requiring renal replacement therapy (RRT) through dialysis or a kidney transplant for survival.Early-stage chronic kidney disease and detection challengesIn CKD's early stages, symptoms often remain absent because healthy nephrons compensate for...
768